☆ 4.3 Article

Ruxolitinib Treatment During Myelofibrosis Leads to Cutaneous Mycobacterium marinum Infection: A Case Report

CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Immunology

Disseminated Mycobacterium avium Complex Myositis in a Patient With Graft-Versus-Host Disease

Kathryn Grace Kompa et al.

Summary: This article reports a case of Mycobacterium avium complex (MAC) pyomyositis and bacteremia in a patient with chronic lymphocytic leukemia, as well as a potential mechanism for the development of disseminated disease. The article highlights that disseminated MAC myositis is rare in individuals without HIV and requires a high index of suspicion for timely diagnosis.

OPEN FORUM INFECTIOUS DISEASES (2022)

添加到收藏夹

Review Oncology

JAK: Not Just Another Kinase

Ruchi P. Agashe et al.

MOLECULAR CANCER THERAPEUTICS (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders

Robert Roskoski

Summary: Janus kinase (JAK) family is a group of nonreceptor protein-tyrosine kinases that regulate mammalian cell signaling. They participate in multiple biological processes including inflammation, hematopoiesis, and immunity, together with various cytokines. Abnormal activation of JAKs is associated with inflammatory disorders and the development of different malignancies. Several JAK inhibitors have been developed and approved for the treatment of related diseases.

PHARMACOLOGICAL RESEARCH (2022)

添加到收藏夹

Article Immunology

Partial human Janus kinase 1 deficiency predominantly impairs responses to interferon gamma and intracellular control of mycobacteria

Vanessa Daza-Cajigal et al.

Summary: Partial JAK1 deficiency predominantly affects susceptibility to mycobacterial infection through impact on the IFN-gamma responsive pathway in myeloid cells. Susceptibility to viral infections as a result of reduced IFN-alpha responses is variable depending on cell type.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Review Infectious Diseases

Cryptococcal fungemia and Mycobacterium haemophilum cellulitis in a patient receiving ruxolitinib: a case report and literature review

Naruemit Sayabovorn et al.

Summary: This case reports a rare coinfection of Cryptococcus neoformans and Mycobacterium haemophilum in a myelofibrosis patient receiving Ruxolitinib treatment. The patient eventually developed septic shock and expired, highlighting the potential for multiple opportunistic infections in patients receiving Ruxolitinib.

BMC INFECTIOUS DISEASES (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?

Przemyslaw J. Kotyla et al.

Summary: Recent advances in immunology have led to the characterization of signal transmitting pathways, among which Janus kinases are essential components. While JAK inhibitors have shown efficacy in treating leukemia and rheumatological disorders, they may also increase the risk of venous thrombosis in patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Rheumatology

The safety of JAK-1 inhibitors

Benjamin Clarke et al.

Summary: As efficacy and safety data emerge, differences between JAK inhibitor subclasses are becoming evident. It is too early to conclude on distinct safety profiles between JAK1 selective agents and other JAK inhibitors, with further research needed for support. Monitoring infection risk, laboratory abnormalities, and herpes zoster reactivation are important considerations when using JAK inhibitors.

RHEUMATOLOGY (2021)

添加到收藏夹

Review Oncology

Mycobacterial Infections With Ruxolitinib: A Retrospective Pharmacovigilance Review

Kartik Anand et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)

添加到收藏夹

Article Hematology

Real-world non-interventional long-term post-authorisation safety study of ruxolitinib in myelofibrosis

Fiorenza Barraco et al.

BRITISH JOURNAL OF HAEMATOLOGY (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Role of JAK inhibitors and immune cells in transplantation

Nicolas Sailliet et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2019)

添加到收藏夹

Review Veterinary Sciences

Mycobacterium marinum infection in fish and man: epidemiology, pathophysiology and management; a review

Emad Hashish et al.

VETERINARY QUARTERLY (2018)

添加到收藏夹

Review Hematology

Ruxolitinib-associated infections: A systematic review and meta-analysis

Federico Lussana et al.

AMERICAN JOURNAL OF HEMATOLOGY (2018)

添加到收藏夹

Review Rheumatology

The emerging safety profile of JAK inhibitors in rheumatic disease

Kevin L. Winthrop

NATURE REVIEWS RHEUMATOLOGY (2017)

添加到收藏夹

Article Immunology

Suppression of Mcl-1 induces apoptosis in mouse peritoneal macrophages infected with Mycobacterium tuberculosis

Fei-yu Wang et al.

MICROBIOLOGY AND IMMUNOLOGY (2016)

添加到收藏夹

Review Infectious Diseases

Twenty-eight cases of Mycobacterium marinum infection: retrospective case series and literature review

Matthew G. Johnson et al.

INFECTION (2015)

添加到收藏夹

Article Medicine, General & Internal

Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

Alessandro M. Vannucchi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

添加到收藏夹

Article Chemistry, Medicinal

Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases

James D. Clark et al.

JOURNAL OF MEDICINAL CHEMISTRY (2014)

添加到收藏夹

Article Medicine, General & Internal

JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis

Claire Harrison et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.